Remote Senior MSL, Lymphoma (Lacutamab): CTCL Expert

Swedish Orphan Biovitrum AB (publ); Chicago (IL); Remote; USD 215,000 - 230,000; Full time

Benefits offered by this job

Competitive pay

Generous leave

Conferences access

Work-life balance

Collaborative culture

Job summary

Sobi is hiring Senior Medical Science Liaisons, Lymphoma (Lacutamab). The role supports CTCL medical strategy and field execution across a US geography, with strong preference for proximity to a major airport.

You will build trusted relationships with clinicians, exchange data, and inform medical strategy. You will contribute to launch readiness, education, and congress activities, while collaborating across Medical Affairs and cross-functional teams to advance rare disease care and patient

Qualifications

• Education: Accredited doctorate in a life-science, health-science, or basic-science discipline (PharmD, PhD, MD, DO, DNP, DSc).
• Experience: At least 5 years of MSL experience in hematology/oncology; rare disease and/or product launch experience preferred.
• Scientific acumen: Ability to understand and clearly communicate complex scientific information.

Responsibilities

• Serve as field-based scientific contact for your assigned US geography.
• Build meaningful relationships with key opinion leaders, HCPs, and medical organizations.
• Exchange balanced information on CTCL, lacutamab, and clinical data.
• Identify field insights to inform medical strategy and engagement plans.
• Execute territory medical plans aligned with CTCL lacutamab strategy.

Skills

Stakeholder engagement

Communication

Collaboration

Execution

Integrity and compliance

Patient focus

Education

Accredited doctorate degree (PharmD/PhD/MD/DO/DNP/DSc)

Job description

Sobi is hiring Senior Medical Science Liaisons, Lymphoma (Lacutamab). The role supports CTCL medical strategy and field execution across a US geography, with strong preference for proximity to a major airport.

You will build trusted relationships with clinicians, exchange data, and inform medical strategy. You will contribute to launch readiness, education, and congress activities, while collaborating across Medical Affairs and cross-functional teams to advance rare disease care and patient